{
  "ticker": "MYX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959272",
  "id": "02959272",
  "pages": 10,
  "price_sensitive": false,
  "date": "20250617",
  "time": "1602",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250617/pdf/06ktwkx23nv7py.pdf",
  "summary": "### Material Information Summary:  \n**Notice of Ceasing to be a Substantial Holder (MAYNE PHARMA GROUP LIMITED)**  \n\n- **Substantial Holder:** Morgan Stanley and subsidiaries  \n- **Ceased to be substantial holder on:** June 12, 2025 (previously held \u22655%)  \n- **Key Transactions (June 6\u201312, 2025):**  \n  - **Net Sell Activity:** Aggregated large-scale disposals (e.g., 93,468 shares sold on June 12 for ~$494,445).  \n  - **Collateral Adjustments:** Returned 1,105,818 shares via Morgan Stanley & Co. International plc on June 12.  \n- **Relevance:** Signals reduced institutional exposure; potential liquidity impact from large disposals.  \n\n*Note: Detailed trades omitted; focus on net material changes to ownership.*",
  "usage": {
    "prompt_tokens": 8516,
    "completion_tokens": 184,
    "total_tokens": 8700,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-17T06:32:55.169369"
}